Floatz logo

MARBLE DUST

Nonalcoholic Fatty Liver

Aristotle University Of ThessalonikiSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Nonalcoholic Fatty Liver cohort.

Asset / SponsorPhaseRating
Denifanstat
Sagimet Biosciences Inc.
Phase 3BB
Zoladex
Aristotle University Of Thessaloniki
Phase 4BB
pxl770
Poxel SA
Phase 2BB
Pioglitazone
The University of Texas Medical Branch, Galveston
Phase 4BB
Denosumab
Aristotle University Of Thessaloniki
Phase 4B

View all 12 →

Same molecule, other indications

MARBLE DUST is also rated in:

colorectal cancerDormant
BB
Indicative ·
71 / 100
View asset →
colon adenomaDormant
BB
Indicative ·
68 / 100
View asset →
Osteoporosis, PostmenopausalDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →